New Processor Information Summary

Exciting news is on the way from Advanced Bionics, Cochlear, and MED-EL!  AB and MED-EL are on the verge of introducing new processors, and Cochlear is making the Nucleus 7 and Kanso 2 processors available to N22 recipients.

Advanced Bionics

Advanced Bionics Sky CI M90The United States Federal Communications Commission has approved the radio-frequency components of a new family of processors from Advanced Bionics.  According to the report, there will be three versions, presumably offered in different markets around the world, and with different feature sets.  The three processors are identified as Naída CI M30, Naída CI M60, and Sky CI M90.  The accented character isn’t in the FCC documentation, but the assumption is that it will mirror the current family of processors.

More information is sure to be coming from Advanced Bionics.  But based on sister company Phonak’s Marvel line of hearing aids, the M series will likely include direct wireless streaming from both Android and iPhones.  And it appears they will be somewhat smaller than the current Q series processors.

 

Cochlear

Cochlear Nucleus 7 processorCochlear Kanso 2The Nucleus 7 processor and the Kanso 2 processor have received FDA approval for N22 recipients.  This FDA approval paves the way for the company to make the processors available to N22 recipients.  Cochlear continues to support its legacy users by making the latest technology available to the greatest extent possible.

See the press release for more information.  And this helpful Cochlear processor comparison chart describes the differences between your current processor and the Nucleus 7 or the Kanso 2.

 

 

MED-EL

MED-EL RONDO 3The new RONDO 3 has its own page on the MED-EL web site!  The processor has a high-tech look with its array of holes.  And it introduces a second microphone so that it can focus on sounds coming from directly in front, which is helpful in noisy situations.  The rechargeable battery life is up to 24 hours, while that of its predecessor was up to 18 hours.

Wireless streaming is accomplished with an intermediary device, the AudioLink.

While MED-EL claims that the Rondo 3 is compatible with all hearing aids, the only compatibility is that you can wear any hearing aid on one side, and the RONDO 3 on the other side.  There is no provision for the RONDO 3 and any hearing aid to stream from one side to the other, to work in concert on noise reduction strategies, or to stream to both side simultaneously, unless the RONDO 3 has a telecoil.

 

Study Shows that Improved Cochlear Implant Device Allows Safe MRI in Children without Discomfort

MED-EL SYNCHRONY implant

A study from Ann Robert H. Lurie Children’s Hospital of Chicago found that children with a MED-EL SYNCHRONY cochlear implant device can undergo MRI safely, with no discomfort and reduced need for sedation or anesthesia. Findings were published in the peer-reviewed journal Laryngoscope.

The study only included subjects with the MED-EL SYNCHRONY implant, which has a rotating magnet that aligns with the MRI magnetic field.  The HiRes Ultra 3D implant from Advanced Bionics has magnets that rotate in multiple axes, so the head can be in any orientation.  The Nucleus 7 implant from Cochlear has a rotating magnet for MRI compatibility as well.

MED-EL SONNET 2 Processor

SONNET 2 Next Generation Audio Processor with MAESTRO 8 Software Now Available from MED-EL USA

MED-EL SONNET 2

Processor Pairs to New Remote Options AudioKey App and FineTuner Echo for Optimal Control and Connectivity

January 6, 2020 – (DURHAM, NC) – MED-EL USA announced today that the new SONNET 2 audio processor is now available. Because MED-EL cochlear implants are engineered for future-readiness, recipients with any MED-EL internal system can enjoy the benefits of the new SONNET 2. The processors are programmed using the recently FDA-approved MAESTRO 8 software that has been optimized for audiologists with guided workflows that show each step in the fitting process, suggesting tasks and tools along the way. The updated software also includes extended data logging functions for hearing health professionals.

SONNET 2 connects to smartphones and tablets using Bluetooth and the new AudioLink device, which is also now available, so that users can stream phone calls and music wirelessly to their ears. Users can choose how they would like to change settings: either from the AudioKey app (available for both iPhones and Android devices) or the FineTuner Echo remote control, both of which were also launched today.

Both the AudioKey app and the FineTuner Echo enable recipients to adjust the volume and switch between programs on their SONNET 2. AudioKey offers a number of family-friendly tools including a special “find my processor” feature that allows users to locate a missing SONNET 2 processor with a near-field search within one meter. With the industry-leading “Guardian Role” function, adults can adjust the settings on a child’s audio processor from a phone and keep a record of their hearing statistics. AudioKey is the only app that allows parents to pair more than one audio processor with their phone, which is ideal if they have multiple children with cochlear implants. AudioKey is also the only app where parents and guardians can assign different levels of control to multiple people, so that every caregiver (including teachers, daycare sitters, grandparents, and even the user as they mature) can observe, control or administrate the recipient’s processors from their own phones.

For recipients who prefer an independent remote control, the new pocket-size FineTuner Echo offers an intuitive display screen that makes it simple to adjust settings, and an e-ink display that makes the screen easy to read on sunny days. The FineTuner Echo allows users to test the microphones of their or their child’s audio processor to quickly check if a device is working correctly.

“The seamless compatibility between SONNET 2, FineTuner Echo and AudioKey offers our cochlear implant users the latest in audio processing technology and wireless connectivity,” said Raymond Gamble, President & CEO, MED-EL North America. “We are particularly excited about family-friendly features like ‘Find my Processor’ and ‘Guardian Role’ that can help alleviate some of the more stressful scenarios for parents of children with cochlear implants. We also know that the unique ability to pair AudioKey to more than one audio processor is a real benefit to families with more than one MED-EL recipient.”

For more information about SONNET 2, FineTuner Echo, AudioKey or any of MED-EL’s products, visit https://www.JourneytoBetterHearing.com/.

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first microelectronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has grown to more than 2,000 employees and 30 locations worldwide.

The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 123 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system as well as surgical and non-surgical bone conduction systems. www.medel.com

FDA Approves MED-EL USA’s Cochlear Implants for Single-Sided Deafness and Asymmetric Hearing Loss

MED-EL SYNCRONY

July 19, 2019 – (DURHAM, NC) – MED-EL USA announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s cochlear implant system for single-sided deafness (SSD) and asymmetric hearing loss (AHL). This is the first and only time that cochlear implants have been approved for these indications in the United States.

Read the official press release here.

AudioLink and SONNET Benefits for new MED-EL Recipients

MED-EL USA announces two programs for new recipients in the USA or Canada.

  • You will receive a voucher for the AudioLink handsfree wireless technology interface (Bluetooth gateway device) that is expected to be available in Fall 2019.
  • A new SONNET Swap program where new US recipients with an unopened  SONNET EAS audio processor can exchange it for the next generation SONNET (already known as SONNET 2 in other markets) once it becomes available, also expected late 2019.

Read the full press release here.

MED-EL RONDO 2 Receives FDA Approval

MED-EL RONDO 2

MED-EL announced today the US Food and Drug Administration (FDA) approval of the RONDO 2 cochlear implant audio processor.  Just place the RONDO 2 on the charge pad and it will charge automatically without wires or cables. The rechargeable battery provides up to 18 hours of battery life, and recharges after four hours.

Product availability is estimated in Fall 2018.  For more information, read the press release here.

MED-EL RONDO 2 Announcement

MED-EL Announces RONDO 2: A True Revolution in Cochlear Implants

RONDO 2 is the first cochlear implant audio processor that can be charged wirelessly. This ground-breaking new design takes away the need for disposable batteries, making RONDO 2 the easiest-to-use audio processor ever made.

MED-EL RONDO 2

September 15, 2017 — (Innsbruck, Austria) — MED-EL, leading provider of hearing loss solutions, has launched the first cochlear implant audio processor with wireless charging.

Powering up RONDO 2 couldn’t be easier. Users simply have to place it on the charging pad and it will charge automatically. Each 4 hour charge gives an exceptional 18 hours of battery life—in other words, a full day of hearing from one overnight charge.

This simple design means that for the first time, cochlear implant users will not have to deal with the hassles of changing batteries or adjusting their processor. They can just put on RONDO 2 each morning, and then forget about it for the rest of the day.

“We’re so used to charging our mobile devices at home overnight,” says Gregor Dittrich, Director of Product Management at MED-EL. “You charge your phone and tablet in this way, so why not your audio processor? It’s the next logical step for cochlear implants and we’re so excited to be pioneering the way forward”.

RONDO 2’s single-unit design is sleeker and more streamlined than ever before. It is perfect to wear with glasses or hide completely under hair. With the interchangeable Design Covers, users can also make RONDO 2 blend in with their natural hair colour, or match their own unique style.

And of course, with waterproof covers, and Bluetooth accessories for easy connectivity with phones—RONDO 2 is ideal for a busy, modern lifestyle.

RONDO 2 will be available from the beginning of 2018, depending on country. Visit rondo2.medel.com for more information.